Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.

Authors: Wang, Quan; Trevino, Lindsey S; Wong, Rebecca Lee Yean; Medvedovic, Mario; Chen, Jing; Ho, Shuk-Mei; Shen, Jianjun; Foulds, Charles E; Coarfa, Cristian; O'Malley, Bert W; Shilatifard, Ali; Walker, Cheryl L

Published In Mol Endocrinol, (2016 Aug)

Abstract: Tissue and organ development is a time of exquisite sensitivity to environmental exposures, which can reprogram developing tissues to increase susceptibility to adult diseases, including cancer. In the developing prostate, even brief exposure to endocrine-disrupting chemicals (EDCs) can increase risk for developing cancer in adulthood, with disruption of the epigenome thought to play a key role in this developmental reprogramming. We find that EDC-induced nongenomic phosphoinositide 3-kinase; (PI3K) signaling engages the histone methyltransferase mixed-lineage leukemia 1 (MLL1), responsible for the histone H3 lysine 4 trimethylation (H3K4me3) active epigenetic mark, to increase cleavage and formation of active MLL1 dimers. In the developing prostate, EDC-induced MLL1 activation increased H3K4me3 at genes associated with prostate cancer, with increased H3K4me3 and elevated basal and hormone-induced expression of reprogrammed genes persisting into adulthood. These data identify a mechanism for MLL1 activation that is vulnerable to disruption by environmental exposures, and link MLL1 activation by EDCs to developmental reprogramming of genes involved in prostate cancer.

PubMed ID: 27219490 Exiting the NIEHS site

MeSH Terms: Animals; Blotting, Western; Chromatin Immunoprecipitation; DNA-Binding Proteins/genetics; DNA-Binding Proteins/metabolism*; Disease Models, Animal; Endocrine Disruptors/toxicity; Environmental Exposure/adverse effects; Epigenesis, Genetic/drug effects; Epigenesis, Genetic/genetics*; HEK293 Cells; Histone-Lysine N-Methyltransferase/genetics*; Histone-Lysine N-Methyltransferase/metabolism*; Histones/metabolism; Humans; Immunohistochemistry; MCF-7 Cells; Male; Methyltransferases/genetics; Methyltransferases/metabolism*; Myeloid-Lymphoid Leukemia Protein/genetics*; Myeloid-Lymphoid Leukemia Protein/metabolism*; Neoplasm Proteins/genetics; Neoplasm Proteins/metabolism*; Phosphatidylinositol 3-Kinases/genetics; Phosphatidylinositol 3-Kinases/metabolism; Prostatic Neoplasms/etiology; Prostatic Neoplasms/genetics; Prostatic Neoplasms/metabolism*; RNA, Small Interfering/genetics; RNA, Small Interfering/physiology; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction/drug effects; Signal Transduction/genetics

to Top